Company profile for mAbTree Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

mAbTree Biologics is a biotechnology company based in Basel, Switzerland, focused on developing innovative, affordable monoclonal antibody therapies for cancer and other life-threatening diseases, with a strong emphasis on immuno-oncology and hematological indications. The company’s interdisciplinary team advances next-generation biologics designed to enhance immune responses against tumors and address unmet treatment needs....
mAbTree Biologics is a biotechnology company based in Basel, Switzerland, focused on developing innovative, affordable monoclonal antibody therapies for cancer and other life-threatening diseases, with a strong emphasis on immuno-oncology and hematological indications. The company’s interdisciplinary team advances next-generation biologics designed to enhance immune responses against tumors and address unmet treatment needs. Through strategic partnerships and rigorous research, mAbTree aims to transform cancer care and expand global patient access to breakthrough therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Technologiepark Basel Hochbergerstrasse 60c 4057 Basel
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/drug-approval/shilpa-biologicals-and-mabtree-biologics-secure-odd-from-usfda-19345

INDPHARMAPOST
14 Mar 2026

https://www.indianpharmapost.com/drug-approval/shilpa-medicare-mabtree-biologics-win-fda-nod-for-rare-blood-cancer-therapy-18998

INDPHARMAPOST
30 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty